SurePrint Oligo Pools

Agilent SurePrint pooled oligo synthesis is an advanced and high throughput production scale parallel DNA synthesis platform. The SurePrint platform has been continuously improved on and optimized over the course of 25 years of innovation and uses state-of-the-art microfluidic DNA writing technology in a process that runs in continuous 24/7 operation for fully custom oligo pools made in rapid turn-around-times.Every custom oligo pool is synthesized under stringent process monitoring quality control for exceptional uniformity and consistency making them well suited for protein engineering, directed evolution, gene assembly and pooled CRISPR screening.Agilent Technologies self-attests that the company adheres to the U.S. Office of Science and Technology Policy (OSTP) Framework for Nucleic Acid Synthesis Screening.Agilent Technologies agrees to promptly update this statement should there be any changes to compliance or to the screening framework.